Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy
暂无分享，去创建一个
T. D. de Gruijl | Hongjie Wang | A. Hemminki | M. Siurala | Simona Bramante | L. Vassilev | S. Parviainen | S. Tähtinen | A. Kanerva | O. Hemminki | S. Hemmi | A. Lieber | Sadia Zafar | R. Havunen